Valuation: Hikal Limited

Market Cap 26.73B 282M 251M 233M 211M 396M 403M 2.79B 1.1B 13.99B 1.06B 1.04B 44.63B P/E 2027 *
72.3x
P/E 2028 * 24.1x
Enterprise Value 26.73B 282M 251M 233M 211M 396M 403M 2.79B 1.1B 13.99B 1.06B 1.04B 44.63B EV / Sales 2027 *
1.43x
EV / Sales 2028 * 1.26x
Free-Float
30.9%
Yield 2027 *
-
Yield 2028 * -
1 day+0.63%
1 week+2.05%
Current month-0.46%
1 month-4.11%
3 months-5.31%
6 months+12.83%
Current year-4.45%
1 week 211.3
Extreme 211.3
220
1 month 207.95
Extreme 207.95
241.05
Current year 145.95
Extreme 145.95
256.7
1 year 145.95
Extreme 145.95
260.8
3 years 145.95
Extreme 145.95
464.5
5 years 145.95
Extreme 145.95
595
10 years 57
Extreme 57
742
Manager TitleAgeSince
Chief Executive Officer 52 1995-12-31
Director of Finance/CFO - 2020-11-04
Chief Tech/Sci/R&D Officer - 2024-12-25
Director TitleAgeSince
Chairman 78 2012-05-15
Chairman 52 2026-09-30
Director/Board Member 51 2010-07-21
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%+2.05%-9.63%-24.43% 282M
+3.34%+10.17%+58.87%+119.83% 1,106B
+1.94%+4.27%+33.81%+69.42% 612B
+2.16%+5.43%+24.64%+97.80% 500B
+2.58%+8.37%+38.71%+63.14% 367B
+3.31%+4.30%+71.55%+44.23% 354B
+1.85%+6.04%+21.47%+49.17% 286B
+1.76%+6.07%+0.43%+20.98% 256B
+2.33%+5.40%+43.46%+56.07% 230B
+2.01%+5.77%+27.09%+101.11% 190B
Average +2.11%+2.12%+31.04%+59.73% 390.04B
Weighted average by Cap. +2.49%+2.30%+40.77%+80.55%

Financials

2027 *2028 *
Net sales 18.64B 197M 175M 162M 147M 276M 281M 1.95B 765M 9.76B 738M 723M 31.12B 21.28B 225M 200M 185M 168M 316M 321M 2.22B 873M 11.14B 843M 825M 35.52B
Net income 374M 3.95M 3.51M 3.26M 2.95M 5.55M 5.64M 39.08M 15.35M 196M 14.81M 14.5M 624M 1.11B 11.74M 10.45M 9.68M 8.77M 16.49M 16.77M 116M 45.65M 582M 44.03M 43.12M 1.86B
Net Debt - -
Projected Income Statement - Annual - Hikal Limited
Logo Hikal Limited
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, and hemorheologic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID. Its crop protection products are used in algaecide, biocide, fungicide, herbicide, insecticide, and intermediate. It offers contract research services for synthesis, process development, and manufacturing projects.
Employees
2,152
Date Price Change Volume
26-10-19 ₹216.80 +0.63% 16,031
26-10-16 ₹215.45 -0.37% 7,269
26-10-15 ₹216.25 -1.05% 9,357
26-10-14 ₹218.55 +2.49% 13,337
26-10-13 ₹213.25 +0.38% 13,406
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
216.80INR
Average target price
300.00INR
Spread / Average Target
+38.38%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Hikal Limited
  1. Stock Market
  2. Stocks
  3. HIKAL Stock